Profile
Bryan Giraudo is the Chief Operating Officer and Chief Financial Officer at Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on developing therapeutics for immunology, inflammation, and oncology. He has been involved in the company's operations and financial management, contributing to its growth and strategic direction.
| Role | Director |
|---|
| Notability | 30/100 |
|---|
Board memberships
Awards & honors
- Leadership in financial management
- Operational strategy development at Gossamer Bio
Frequently Asked Questions
Who is Giraudo Bryan?
Bryan Giraudo is the Chief Operating Officer and Chief Financial Officer at Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on developing therapeutics for immunology, inflammation, and oncology. He has been involved in the company's operations and financial management, contributing to its growth and strategic direction.…
How many SEC Form 4 filings has Giraudo Bryan submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Has Giraudo Bryan been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($5.92M) across all tracked filings.
Where can I see all of Giraudo Bryan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.